You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0178 Clinical Responses of Sarilumab Based on Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide Antibody Status in Patients with Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0178 Clinical Responses of Sarilumab Based on Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide Antibody Status in Patients with Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016902
Aug 2016702
Sep 20161605
Oct 2016801
Nov 2016801
Dec 20161901
Jan 20172501
Feb 20171701
Mar 20171609
Apr 2017700
May 20171103
Jun 20171001
Jul 2017601
Aug 20172401
Sep 20171600
Oct 20171001
Nov 20171400
Dec 20171800
Jan 20182201
Feb 20181402
Mar 20181203
Apr 2018400
May 2018600
Jun 20181800
Jul 20181400
Aug 20181600
Sep 20181401
Oct 20181000
Nov 20181401
Dec 20181000
Jan 2019800
Mar 2019600
Apr 2019400
May 2019200
Jun 2019200
Jul 20194304
Aug 2019800
Sep 2019800
Oct 2019400
Nov 20191401
Dec 2019601
Jan 2020600
Feb 2020300
Jun 20201300
Jul 20201400
Aug 20201601
Sep 20203100
Oct 2020801
Nov 20201400
Dec 20201600
Jan 2021600
Feb 2021800
Mar 2021801
Apr 2021600
May 2021200
Oct 2021100
Nov 20211200
Dec 20211000
Jan 2022400
Feb 20221200
Mar 20221000
May 20222000
Jun 2022200
Jul 2022800
Aug 2022800
Sep 2022400
Oct 20224001
Nov 20221000
Dec 20221200
Jan 2023800
Feb 2023600
Mar 2023400
Apr 2023200
May 2023400
Jul 2023400
Aug 2023200
Sep 20231000
Oct 2023200
Nov 2023200
Dec 2023800
Jan 2024600
Feb 2024200
Mar 2024400
Total868048